During the past decade, Cardiovascular Consultants of Maine, PA conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cardiovascular Consultants of Maine, PA" #1 sponsor was "Gilead Sciences" with 2 trials, followed by "American Regent, Inc." with 1 trials sponsored, "Bayer" with 1 trials sponsored, "Cardiovascular Clinical Studies" with 1 trials sponsored and "Cogentus Pharmaceuticals" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cardiovascular Consultants of Maine, PA" #1 collaborator was "GE Healthcare" with 2 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Cardiovascular Consultants of Maine, PA" are "Coronary Artery Disease" (3 trials), "Heart Failure" (2 trials), "Hypertension" (2 trials), "Acute Coronary Syndrome" (1 trials) and "Cardiovascular Disease" (1 trials). Many other conditions were trialed in "Cardiovascular Consultants of Maine, PA" in a lesser frequency.

Most popular intervention types in "Cardiovascular Consultants of Maine, PA" are "Drug" (6 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Darusentan" (2 trials), "Placebo" (2 trials), "Adenosine SPECT myocardial perfusion imaging" (1 trials), "CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin" (1 trials) and "Combined adenosine / exercise SPECT myocardial perfusion imaging" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cardiovascular Consultants of Maine, PA" are 6 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Cardiovascular Consultants of Maine, PA". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Cardiovascular Consultants of Maine, PA, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Cardiovascular Consultants of Maine, PA, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".